Outcomes from Referral to Transplant for Patients with MASLD: A California Liver Network Study

By afschroeder • November 13, 2025

Lim TY, Steggerda JA, Trivedi H, Luu M, Vipani A, Adjei MA, Singh J, Zhou K, Kwong A, Tincopa M, Vodkin I, Ajmera V, Mehta N, Freise CE, Yilma M, Hirose R, Kuo A, Wisel SA. Outcomes from Referral to Transplant for Patients with MASLD: A California Liver Network Study. J Clin Med. 2025 Nov 4;14(21):7841. doi: 10.3390/jcm14217841. PMID: 41227237.

Tags: Digestive Diseases, liver transplantation, Metabolic dysfunction-associated steatotic liver disease, Publications, transplantation evaluation

Characterization of the Fecal Metabolome in Patients With Early Systemic Sclerosis

Young AC, Andréasson K, Labus J, Matulionis N, Jacobs JP, Christofk H, Volkmann ER. Characterization of the Fecal Metabolome in Patients With Early Systemic Sclerosis.[...]

Pancreatic Cystic Lesions in the Older Patient: A Review of Clinical Guidelines and Management

Shah S, Muthusamy VR. Pancreatic Cystic Lesions in the Older Patient: A Review of Clinical Guidelines and Management. Curr Gastroenterol Rep. 2025 Nov 11;27(1):72. doi:[...]

The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint

Brenner DM, Shin AS, Laitman AP, Deutsch JK, Kunkel DC. The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years[...]